Related Experiment Video

Updated: May 3, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K

Pathway-based analysis of the hidden genetic heterogeneities in cancers

Xiaolei Zhao1, Shouqiang Zhong2, Xiaoyu Zuo3

  • 1Institute for Medical Systems Biology and Department of Medical Statistics and Epidemiology, School of Public Health, Guangdong Medical College, Dongguan 523808, China.

Genomics, Proteomics & Bioinformatics
|January 28, 2014
PubMed

Insights

Pathway-based approaches can uncover hidden cancer subtypes. This method successfully identified distinct molecular subtypes in diffuse large B-cell lymphoma (DLBCL), revealing significant differences in patient survival rates.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Cancers with similar appearances can have distinct molecular profiles, impacting treatment efficacy.
  • Pathway-based approaches show promise for robust genetic analysis in cancer.
  • The utility of function-based approaches for identifying cancer molecular heterogeneity remains under investigation.

Purpose of the Study:

  • To evaluate the effectiveness of pathway-based approaches in partitioning cancer samples.
  • To identify and characterize hidden molecular subtypes within diffuse large B-cell lymphoma (DLBCL).
  • To assess the clinical significance of identified subtypes using survival analysis.

Main Methods:

  • Validation of pathway-based partitioning using the NCI60 cancer cell line dataset.
  • Application of the pathway-based method to identify subtypes in a DLBCL patient cohort.
  • Survival analysis to correlate identified subtypes with clinical outcomes.

Main Results:

  • The pathway-based approach accurately partitioned the NCI60 dataset, aligning with known clinical cancer phenotypes.
  • Three distinct hidden subtypes were identified in the DLBCL dataset.
  • These DLBCL subtypes exhibited significantly different 10-year overall survival rates (90%, 46%, and 20%), with P=0.008.

Conclusions:

  • Pathway-based analysis is a promising strategy for uncovering genetic heterogeneities in complex diseases like cancer.
  • The identified DLBCL subtypes have significant clinical implications for patient prognosis.
  • This approach can aid in understanding and potentially tailoring treatments for molecularly distinct cancer subtypes.
Keywords:
CancerEnrichment analysisGenetic heterogeneityPathway-based approachSample partitioningSurvival analysis

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.0K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.1K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K